|
|
19-May-2012
Dabrafenib is safe in patients with solid tumours, and an active inhibitor of Val600-mutant BRAF...
|
|
19-May-2012
These findings provide evidence for the short-term benefits of minimally invasive oesophagectomy...
|
|
19-May-2012
Pazopanib is a new treatment option for patients with metastatic non-adipocytic soft-tissue sarcoma...
|
|
19-May-2012
A 65-year-old man was referred by his general practitioner for an ECG at our hospital after a...
|
|
19-May-2012
In The Lancet, Gerald Falchook and colleagues present results from a phase 1 trial of dabrafenib in...
|
|
19-May-2012
In May, 2002, under the auspices of its Advisory Committee on Health Research, WHO released...
|
|
19-May-2012
In The Lancet, findings from Surya Biere and colleagues' multicentre randomised trial comparing...
|
|
19-May-2012
Sitting over lunch with a scientist who serves on the governing body of a well-known UK research...
|
|
19-May-2012
Development of new therapeutics for adults with metastatic soft-tissue sarcoma has been...
|
|
19-May-2012
The NCD Alliance aims to put non-communicable diseases (NCDs) on the global agenda to address the...
|
|
